Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-21 Sale |
2023-02-22 8:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,848 | $46.83 | $1,304,000 | 1,100,309 (Direct) |
View |
| 2022-12-19 Sale |
2022-12-21 4:06 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
5,000 | $50.82 | $254,100 | 39,233 (Indirect Direct) |
View |
| 2022-12-13 Sale |
2022-12-15 7:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
33,083 | $55 | $1,819,565 | 1,100,309 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 7:14 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $53.73 | $2,686,514 | 15,164 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-08 4:12 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
10,000 | $52.3 | $523,023 | 44,233 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 9:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
65,164 | $45.63 | $2,973,406 | 0 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 6:09 pm |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
30,000 | $57.13 | $1,713,975 | 19,043 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 6:05 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
10,000 | $59.22 | $592,200 | 54,233 (Indirect Direct) |
View |
| 2022-05-12 Sale |
2022-05-13 5:24 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
10,000 | $55 | $550,000 | 64,233 (Indirect Direct) |
View |
| 2022-04-08 Sale |
2022-04-08 6:56 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
86,348 | $64.37 | $5,558,051 | 45,339 (Direct) |
View |
| 2022-03-16 Sale |
2022-03-18 8:12 pm |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
226,670 | $60.1 | $13,623,979 | 76,815 (Indirect Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 9:49 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $53.14 | $1,062,750 | 69,663 (Indirect Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 6:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
8,037 | $56.28 | $452,313 | 23,104 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 7:09 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
4,046 | $52.27 | $211,468 | 46,954 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 7:08 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,906 | $52.21 | $412,810 | 61,152 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 7:06 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,906 | $51.98 | $410,933 | 15,813 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 7:04 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
7,454 | $51.97 | $387,349 | 14,910 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-25 7:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
22,589 | $51.98 | $1,174,074 | 1,139,647 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-23 7:08 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
4,177 | $55.29 | $230,958 | 35,635 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-18 Exercise |
2023-02-22 8:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,848 | $0 | 1,100,309 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
97 | $52.92 | 9,250 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:18 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
321 | $52.92 | 78,047 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:14 pm |
N/A 2028-01-03 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $0 | 15,164 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 7:14 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $15.47 | 15,164 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-05 4:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
110 | $46.53 | 9,153 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-04 4:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
365 | $46.53 | 77,726 (Direct) |
View |
| 2022-09-21 Exercise |
2022-09-23 9:01 pm |
N/A 2028-01-03 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
65,164 | $0 | 0 (Direct) |
View |
| 2022-09-21 Exercise |
2022-09-23 9:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
65,164 | $15.47 | 0 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 6:09 pm |
N/A 2027-06-27 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
30,000 | $0 | 19,043 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 6:09 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $12.45 | 19,043 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 6:09 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
10,000 | $13.05 | 19,043 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 4:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
108 | $57.08 | 9,043 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 4:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
289 | $57.08 | 77,361 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:11 pm |
2023-06-09 2032-06-08 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
16,757 | $0 | 16,757 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:08 pm |
2023-06-09 2032-06-08 |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
16,757 | $0 | 16,757 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:06 pm |
2023-06-09 2032-06-08 |
Intra-Cellular Therapies Inc. | ITCI | Rawlins Michael Director |
16,757 | $0 | 16,757 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:03 pm |
2023-06-09 2032-06-08 |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
16,757 | $0 | 16,757 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:01 pm |
2023-06-09 2032-06-08 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
16,757 | $0 | 16,757 (Direct) |
View |
| 2019-06-18 Exercise |
2022-05-13 5:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
14,189 | $0 | 64,233 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-21 4:54 pm |
2023-04-20 2032-04-20 |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-08 6:56 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
86,348 | $12.73 | 45,339 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-08 6:56 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
86,348 | $0 | 45,339 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
126 | $61.19 | 8,935 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
257 | $61.19 | 77,072 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:15 pm |
N/A 2032-03-09 |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
39,950 | $0 | 39,950 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:13 pm |
N/A 2032-03-09 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
39,950 | $0 | 39,950 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:07 pm |
N/A 2032-03-09 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
39,950 | $0 | 39,950 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:06 pm |
N/A 2032-03-09 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
30,362 | $0 | 30,362 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:03 pm |
N/A 2032-03-09 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
111,863 | $0 | 111,863 (Direct) |
View |
| 2022-03-09 Exercise |
2022-03-10 4:13 pm |
N/A 2022-04-30 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
38,925 | $0 | 1,133,392 (Direct) |
View |
| 2022-03-09 Exercise |
2022-03-10 4:13 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
38,925 | $2.84 | 1,133,392 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 7:09 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
7,906 | $0 | 46,954 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 7:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,906 | $0 | 61,152 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 7:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,906 | $0 | 15,813 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 7:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
7,454 | $0 | 14,910 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 7:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
22,589 | $0 | 1,139,647 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-23 7:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
8,354 | $0 | 35,635 (Direct) |
View |